Profile
Full Name
Neumora Therapeutics, Inc.Ticker Symbol
NMRAExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
September 15, 2023Indexes
Not includedWebsite
http://www.neumoratx.comEmployees
110Key Details
Price
$0.63(-3.96%)
Market cap
$102.05M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.53(+57.85% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Neumora Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 10, 25 Needham
BuyApr 2, 25 B of A Securities
UnderperformMar 10, 25 Guggenheim
NeutralMar 7, 25 Stifel
HoldMar 7, 25 HC Wainwright & Co.
BuyMar 4, 25 RBC Capital
Sector PerformMar 4, 25 Needham
BuyMar 4, 25 HC Wainwright & Co.
BuyFeb 14, 25 HC Wainwright & Co.
BuyJan 6, 25 B of A Securities
BuyInstitutional Ownership
- What is the ticker symbol for Neumora Therapeutics?
- Does Neumora Therapeutics pay dividends?
- What sector is Neumora Therapeutics in?
- What industry is Neumora Therapeutics in?
- What country is Neumora Therapeutics based in?
- When did Neumora Therapeutics go public?
- Is Neumora Therapeutics in the S&P 500?
- Is Neumora Therapeutics in the NASDAQ 100?
- Is Neumora Therapeutics in the Dow Jones?
- When was Neumora Therapeutics's last earnings report?
- When does Neumora Therapeutics report earnings?
- Should I buy Neumora Therapeutics stock now?
What is the ticker symbol for Neumora Therapeutics?
The ticker symbol for Neumora Therapeutics is NASDAQ:NMRA
Does Neumora Therapeutics pay dividends?
No, Neumora Therapeutics does not pay dividends
What sector is Neumora Therapeutics in?
Neumora Therapeutics is in the Healthcare sector
What industry is Neumora Therapeutics in?
Neumora Therapeutics is in the Biotechnology industry
What country is Neumora Therapeutics based in?
Neumora Therapeutics is headquartered in United States
When did Neumora Therapeutics go public?
Neumora Therapeutics's initial public offering (IPO) was on September 15, 2023
Is Neumora Therapeutics in the S&P 500?
No, Neumora Therapeutics is not included in the S&P 500 index
Is Neumora Therapeutics in the NASDAQ 100?
No, Neumora Therapeutics is not included in the NASDAQ 100 index
Is Neumora Therapeutics in the Dow Jones?
No, Neumora Therapeutics is not included in the Dow Jones index
When was Neumora Therapeutics's last earnings report?
Neumora Therapeutics's most recent earnings report was on Mar 3, 2025
When does Neumora Therapeutics report earnings?
The next expected earnings date for Neumora Therapeutics is May 7, 2025
Should I buy Neumora Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions